Description
The global Neoantigen Peptides Manufacturing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Olid Phase Synthesis Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Neoantigen Peptides Manufacturing include Cpc Scientific Inc, Polypeptide Group, Genscript Biotech, Kaneka Eurogentec SA, Vivitide, Almac, Bcn Peptides, Creative Peptides and Pepscan, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Neoantigen Peptides Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neoantigen Peptides Manufacturing. This report contains market size and forecasts of Neoantigen Peptides Manufacturing in global, including the following market information:
Global Neoantigen Peptides Manufacturing Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neoantigen Peptides Manufacturing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neoantigen Peptides Manufacturing Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Neoantigen Peptides Manufacturing Market Segment Percentages, by Type, 2022 (%)
Olid Phase Synthesis
Solution Phase Synthesis
Global Neoantigen Peptides Manufacturing Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Neoantigen Peptides Manufacturing Market Segment Percentages, by Application, 2022 (%)
Pharmaceutical/Vaccine Developer Companies
Contract Research Organizations (CRO)
Others
Global Neoantigen Peptides Manufacturing Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Neoantigen Peptides Manufacturing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neoantigen Peptides Manufacturing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Neoantigen Peptides Manufacturing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cpc Scientific Inc
Polypeptide Group
Genscript Biotech
Kaneka Eurogentec SA
Vivitide
Almac
Bcn Peptides
Creative Peptides
Pepscan
Provepharm
Creosalus
Gyros Protein Technologies
Anaspec
Outline of Major Chapters:
Chapter 1: Introduces the definition of Neoantigen Peptides Manufacturing, market overview.
Chapter 2: Global Neoantigen Peptides Manufacturing market size in revenue.
Chapter 3: Detailed analysis of Neoantigen Peptides Manufacturing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Neoantigen Peptides Manufacturing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
